Oncternal Therapeutics (acquired by Tokalas)


Public list: Pharma Startups (4733) Cancer Therapeutics (1133)

Oncternal Therapeutics is a clinical-stage oncology company developing first-in-class and novel therapies for both rare and common cancers by focusing on targets that are uniquely expressed within cancer cells.

Oncternal Therapeutics is a clinical-stage oncology company developing first-in-class and novel therapies for both rare and common cancers by focusing on targets that are uniquely expressed within cancer cells.

Company (Merged)

Phone:

Fax:



San Diego,
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Oncternal Therapeutics (acquired by Tokalas) $0M Jun 1, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Oncternal Therapeutics (acquired by Tokalas) Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Indolinone compounds and uses thereof Nov 21, 2016 Feb 20, 2018 Patent
Indolinone compounds and uses thereof Nov 21, 2016 Application